Literature DB >> 24501131

LILR-B1 blocks activating FcγR signaling to allow antibody dependent enhancement of dengue virus infection.

Falk Nimmerjahn1, Anja Lux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24501131      PMCID： PMC3932889          DOI： 10.1073/pnas.1324286111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  20 in total

Review 1.  Immune inhibitory receptors.

Authors:  J V Ravetch; L L Lanier
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

2.  Primary immunodeficiencies: a field in its infancy.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Science       Date:  2007-08-03       Impact factor: 47.728

Review 3.  Negative signaling in Fc receptor complexes.

Authors:  Marc Daëron; Renaud Lesourne
Journal:  Adv Immunol       Date:  2006       Impact factor: 3.543

4.  Fc receptor but not complement binding is important in antibody protection against HIV.

Authors:  Ann J Hessell; Lars Hangartner; Meredith Hunter; Carin E G Havenith; Frank J Beurskens; Joost M Bakker; Caroline M S Lanigan; Gary Landucci; Donald N Forthal; Paul W H I Parren; Preston A Marx; Dennis R Burton
Journal:  Nature       Date:  2007-09-06       Impact factor: 49.962

Review 5.  Fc receptors are major mediators of antibody based inflammation in autoimmunity.

Authors:  P Mark Hogarth
Journal:  Curr Opin Immunol       Date:  2002-12       Impact factor: 7.486

6.  Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue.

Authors:  Kuan Rong Chan; Eugenia Z Ong; Hwee Cheng Tan; Summer Li-Xin Zhang; Qian Zhang; Kin Fai Tang; Nivashini Kaliaperumal; Angeline Pei Chiew Lim; Martin L Hibberd; Soh Ha Chan; John E Connolly; Manoj N Krishnan; Shee Mei Lok; Brendon J Hanson; Chao-Nan Lin; Eng Eong Ooi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

Review 7.  Low-affinity Fcgamma receptors, autoimmunity and infection.

Authors:  Lisa C Willcocks; Kenneth G C Smith; Menna R Clatworthy
Journal:  Expert Rev Mol Med       Date:  2009-08-13       Impact factor: 5.600

Review 8.  Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes.

Authors:  Scott B Halstead; Suresh Mahalingam; Mary A Marovich; Sukathida Ubol; David M Mosser
Journal:  Lancet Infect Dis       Date:  2010-10       Impact factor: 25.071

9.  A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells.

Authors:  M Colonna; F Navarro; T Bellón; M Llano; P García; J Samaridis; L Angman; M Cella; M López-Botet
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

10.  Selective blockade of the inhibitory Fcgamma receptor (FcgammaRIIB) in human dendritic cells and monocytes induces a type I interferon response program.

Authors:  Kavita M Dhodapkar; Devi Banerjee; John Connolly; Anjli Kukreja; Elyana Matayeva; Maria Concetta Veri; Jeffrey V Ravetch; Ralph M Steinman; Madhav V Dhodapkar
Journal:  J Exp Med       Date:  2007-05-14       Impact factor: 14.307
View more
  8 in total

Review 1.  Review article: Research on dengue during World War II revisited.

Authors:  Grace E Snow; Benjamin Haaland; Eng Eong Ooi; Duane J Gubler
Journal:  Am J Trop Med Hyg       Date:  2014-10-13       Impact factor: 2.345

Review 2.  Leukocyte immunoglobulin-like receptors in human diseases: an overview of their distribution, function, and potential application for immunotherapies.

Authors:  Jilu Zhang; Sunny Mai; Hui-Ming Chen; Kyeongah Kang; Xian Chang Li; Shu-Hsia Chen; Ping-Ying Pan
Journal:  J Leukoc Biol       Date:  2017-03-28       Impact factor: 4.962

3.  Formation of infectious dengue virus-antibody immune complex in vivo in marmosets (Callithrix jacchus) after passive transfer of anti-dengue virus monoclonal antibodies and infection with dengue virus.

Authors:  Meng Ling Moi; Yasushi Ami; Kenji Shirai; Chang-Kweng Lim; Yuriko Suzaki; Yuka Saito; Kazutaka Kitaura; Masayuki Saijo; Ryuji Suzuki; Ichiro Kurane; Tomohiko Takasaki
Journal:  Am J Trop Med Hyg       Date:  2014-12-29       Impact factor: 2.345

Review 4.  New Targets for Antiviral Therapy: Inhibitory Receptors and Immune Checkpoints on Myeloid Cells.

Authors:  Yanni Liu; Paul Nicklin; Yuan He
Journal:  Viruses       Date:  2022-05-25       Impact factor: 5.818

Review 5.  Human gene copy number variation and infectious disease.

Authors:  Edward J Hollox; Boon-Peng Hoh
Journal:  Hum Genet       Date:  2014-06-05       Impact factor: 4.132

Review 6.  Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development.

Authors:  Ruklanthi de Alwis; Shiwei Chen; Esther S Gan; Eng Eong Ooi
Journal:  EBioMedicine       Date:  2020-04-16       Impact factor: 8.143

Review 7.  Leukocyte Immunoglobulin-Like Receptors in Regulating the Immune Response in Infectious Diseases: A Window of Opportunity to Pathogen Persistence and a Sound Target in Therapeutics.

Authors:  Florence Abdallah; Sixtine Coindre; Margaux Gardet; Florian Meurisse; Abderrahim Naji; Narufumi Suganuma; Laurent Abi-Rached; Olivier Lambotte; Benoit Favier
Journal:  Front Immunol       Date:  2021-09-14       Impact factor: 7.561

Review 8.  The Genomic Organization of the LILR Region Remained Largely Conserved Throughout Primate Evolution: Implications for Health And Disease.

Authors:  Lisanne Storm; Jesse Bruijnesteijn; Natasja G de Groot; Ronald E Bontrop
Journal:  Front Immunol       Date:  2021-10-19       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.